NCI Resources

NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - October 2001 Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patients. Prognostic significance of histopathological grading and immunoreactivity for p53 and p21/WAF1 in grade 2 pTa transitional...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - September 2001 Table of Contents[Carcinoma in situ in the urinary bladder]Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women's Health Study.[Differences in survival of patients with bladder cancer depending on depth of...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - October 2001 Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females. Treatment of metastatic urothelial cancer in the post-MVAC era. The role of adjuvant chemotherapy for locally advanced...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - April 2002 Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. The relationship between spontaneous telomere loss and chromosome instability in a human tumor cell line. Cyclin D1 gene polymorphism is associated with an...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - August 2002 Establishment of a mini-gene expression database for bladder tumor. Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization. Cytologic evaluation of urine is important in evaluation of...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - February 2002 [Effect of IGF1 receptor gene antisense oligodeoxynucleotide on T24 urinary bladder cancer cells] Development of a novel rapid assay to assess the fidelity of DNA double-strand-break repair in human tumour cells. Precise microdissection of...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - January 2002 Hemoglobin enhances tissue factor expression on human malignant cells. Latent class modeling approaches for assessing diagnostic error without a gold standard: with applications to p53 immunohistochemical assays in [Cytoscopic follow-up of...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - July 2002 Superficial bladder tumors in patients under 40 years of age: clinical, prognostic and cytogenetic aspects. Genetic aberrations of NAT2 and chromosome 8: their association with progression in transitional cell carcinoma of the urinary...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - June 2002 Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - March 2002 Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - May 2002 Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. The dilemma of suspicious urine cytology in patients being...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - October 2002 A study comparing various noninvasive methods of detecting bladder cancer in urine. Immunohistochemical detection of the 150-kDa oxygen-regulated protein in bladder cancer. Patterns of chromosomal aberrations in urinary bladder tumours...
NCI CANCERLIT^® Search: Diagnosis-Histopathology-Pathogenesis of Bladder Cancer - September 2002 [Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with Improving a nurse-led flexible cystoscopy service through audit. Derivation of nephrogenic adenomas...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - April 2002 St John's wort helps to fight bladder cancer. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin. Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors....
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - August 2002 Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence? Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. Controversies in uro-oncology. Proceedings...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - February 2002 A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. Holmium:YAG laser treatment of recurrent superficial bladder carcinoma: initial clinical experience. [Intravesical instillation of...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - January 2002 Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre An organ-preserving approach to muscle-invading transitional cell cancer of the bladder....
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - July 2002 [Orthotopic bladder from the small intestine following radical cystectomy according to Studer's procedure] Intracavitary therapy of noninvasive transitional cell carcinomas of the upper urinary tract. A review of the literature. A pilot...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - June 2002 [Single instillation of epirubicin for the prophylaxis of recurrent primary superficial bladder carcinoma] [Radical cystectomy for superficial tumors in the BCG era] Randomized study of single early instillation of ...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - March 2002 [Immunocorrective effect of alternating magnetic field in the postoperative period in malignant bladder cancer] Intravesical immunotoxin as adjuvant therapy to prevent the recurrence of bladder cancer. An introduction to aspirin, NSAids,...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - May 2002 [Classification, favorable characteristics, prevention and treatment of adverse side-effects associated with Bacillus Calmette-Guerin in the Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - October 2002 Suicide gene therapy for urogenital cancer: current outcome and prospects. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a Laparoscopic radical...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - September 2002 Evaluation of the cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guerin treatment. N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell...
NCI CANCERLIT^® Search: Therapy of Bladder Cancer - September 2001 Table of Contents[Carcinoma in situ in the urinary bladder]Gemcitabine/carboplatin in advanced urothelial cancer.[Minimally invasive therapy for bladder and prostate cancer]Molecular determination of perivesical and lymph node metastasis after ...
NCI/PDQ^® Health professionals: Bladder and Other Urothelial Cancers Screening (PDQ®) TABLE OF CONTENTS OverviewBenefitsHarmsDescription of the EvidenceIncidence and MortalityRisk FactorsInheritanceClinical PresentationHistopathologyGrade and Stage of Newly Diagnosed Bladder Cancer in an Unscreened PopulationScreening...
NCI/PDQ^® Health professionals: Bladder Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Bladder CancerIncidence and MortalityPrognosisRelated SummariesCellular Classification of Bladder CancerStage Information for Bladder CancerDefinitions of TNMTreatment Option OverviewStage 0 Bladder...
NCI/PDQ^® Pacientes: Cáncer de la vejiga: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de la vejiga Estadios del cáncer de la vejigaCáncer de vejiga recidivante Aspectos generales de las opciones de tratamiento Opciones de tratamiento por estadioCáncer de...
NCI/PDQ^® Patients: Bladder Cancer Treatment (PDQ®) TABLE OF CONTENTS General Information About Bladder CancerStages of Bladder CancerRecurrent Bladder CancerTreatment Option OverviewTreatment Options by Stage Stage 0 (Papillary Carcinoma and Carcinoma in Situ)Stage I Bladder CancerStage II Bladder...
NCI/PDQ^® Patients: Screening for Bladder and Other Urothelial Cancers TABLE OF CONTENTS Overview of ScreeningWhat is screening?Purposes of this summaryBladder Cancer ScreeningRisk of bladder cancerScreening tests for bladder cancerChanges to This Summary (06/21/2005)Questions or Comments About This SummaryTo Learn...
NCI/PDQ^® Profesionales De Salud: Cáncer de la vejiga: Tratamiento (PDQ®) TABLE OF CONTENTS Información general sobre el cáncer de la vejigaIncidencia y mortalidadPronósticoSumarios relacionadosClasificación celular del cáncer de la vejigaInformación sobre los estadios del cáncer de la...